Aptose Picks Up Hanmi’s MKI To Buoy Hematological Cancer Pipeline

$420m Deal Follows Positive Data

 
• By Jung Won Shin
  
leukemia
HM43239 Shows Significant Genotype-Agnostic Anti-Leukemic Activity In Phase I/II • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business